Aurora Cannabis (ACB) Return on Invested Capital (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Return on Invested Capital of 0.0% for Q1 2026, little changed year-on-year from 0.0% in Q1 2025, and up 3238.32% on a QoQ basis from 0.0% in Q4 2025.
Aurora Cannabis (ACB) Return on Invested Capital (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Return on Invested Capital for 9 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.
- Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Invested Capital grew to 0.0% in Q1 2026 per ACB's latest filing, from 0.0% in the prior quarter.
- Over the last five years, Return on Invested Capital for ACB reached as high as 0.0% in Q2 2024 and fell as low as 2.74% in Q2 2022.
- A 5-year average of 0.24% and a median of 0.04% in 2023 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2022 — Return on Invested Capital plunged 273 bps — and 2023, when it soared 260 bps.
- Year by year, Return on Invested Capital stood at 0.15% in 2022, then jumped by 52 bps to 0.07% in 2023, then jumped by 100 bps to 0.0% in 2024, then plunged by 106 bps to 0.0% in 2025, then surged by 3238 bps to 0.0% in 2026.
- According to Business Quant data, Return on Invested Capital over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.01% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.01% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.03% |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.13% |
| Dec 31, 2023 | -0.07% |
| Sep 30, 2023 | -0.07% |
| Jun 30, 2023 | -0.14% |
| Dec 31, 2022 | -0.15% |
| Sep 30, 2022 | -0.32% |
| Jun 30, 2022 | -2.74% |
| Mar 31, 2022 | -0.14% |
| Dec 31, 2021 | -0.08% |
| Sep 30, 2021 | -0.06% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |